DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 7 of 7 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D09959
D09959
Ruxolitinib
[1]
228
228
2
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D09970
D09970
Tofacitinib
[15]
11
11
,
40
,
44
,
46
,
49
,
50
,
51
,
53
,
65
,
84
,
96
,
97
,
107
,
256
,
271
3
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D10308
D10308
Baricitinib
[13]
41
41
,
46
,
49
,
50
,
51
,
53
,
93
,
107
,
162
,
265
,
268
,
269
,
325
4
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D10653
D10653
Peficitinib
[1]
46
46
5
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D10871
D10871
Filgotinib
[6]
46
46
,
53
,
96
,
97
,
222
,
271
6
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D10944
D10944
Itacitinib
[5]
46
46
,
51
,
60
,
97
,
228
7
JAK1
[27]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
NOD-like receptor signaling pathway
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Human T-cell leukemia virus 1 infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Viral carcinogenesis
,
Pancreatic cancer
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
[27]
EGFR tyrosine kinase inhibitor resistance
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Osteoclast
...
D10994
D10994
Upadacitinib
[8]
40
40
,
41
,
46
,
49
,
96
,
97
,
107
,
271